Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis.

Shinto L, Marracci G, Baldauf-Wagner S, Strehlow A, Yadav V, Stuber L, Bourdette D.

Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):131-6. doi: 10.1016/j.plefa.2008.12.001. Epub 2009 Jan 25.

2.

Effect of omega-3 fatty acids on the modification of erythrocyte membrane fatty acid content including oleic acid in peritoneal dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Park Y.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):29-34. doi: 10.1016/j.plefa.2011.10.009. Epub 2011 Nov 8.

PMID:
22071008
3.

Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.

An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y.

Nutr Res. 2012 Jul;32(7):495-502. doi: 10.1016/j.nutres.2012.06.005. Epub 2012 Jul 20.

PMID:
22901557
4.

Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.

Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY.

Clin Chem. 2006 Dec;52(12):2265-72. Epub 2006 Oct 19.

5.

Rapid incorporation of ω-3 fatty acids into colonic tissue after oral supplementation in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.

Sorensen LS, Rasmussen HH, Aardestrup IV, Thorlacius-Ussing O, Lindorff-Larsen K, Schmidt EB, Calder PC.

JPEN J Parenter Enteral Nutr. 2014 Jul;38(5):617-24. doi: 10.1177/0148607113491782. Epub 2013 Jun 20.

PMID:
23788002
6.

Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement.

Sarter B, Kelsey KS, Schwartz TA, Harris WS.

Clin Nutr. 2015 Apr;34(2):212-8. doi: 10.1016/j.clnu.2014.03.003. Epub 2014 Mar 14.

7.

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.

Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N Jr, Palmblad J.

J Intern Med. 2014 Apr;275(4):428-36. doi: 10.1111/joim.12166. Epub 2014 Jan 11.

8.

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, Gallagher E, Venkatraman J, Meksawan K, Deinehert S, Pendergast D, Awad AB, Ramanathan M, Munschauer F, Rudick R.

Prostaglandins Leukot Essent Fatty Acids. 2005 Nov;73(5):397-404.

PMID:
16099630
9.

Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.

Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V.

Clin Neurol Neurosurg. 2006 Feb;108(2):124-8.

PMID:
16412833
10.

Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: effects of omega-3 polyunsaturated fatty acid supplementation.

Signorini C, De Felice C, Leoncini S, Durand T, Galano JM, Cortelazzo A, Zollo G, Guerranti R, Gonnelli S, Caffarelli C, Rossi M, Pecorelli A, Valacchi G, Ciccoli L, Hayek J.

Prostaglandins Leukot Essent Fatty Acids. 2014 Nov;91(5):183-93. doi: 10.1016/j.plefa.2014.08.002. Epub 2014 Sep 6.

PMID:
25240461
11.

The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study.

Lee SM, Son YK, Kim SE, An WS.

Mar Drugs. 2015 Jan 28;13(2):741-55. doi: 10.3390/md13020741.

13.

Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.

Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE.

Pharmacotherapy. 2007 May;27(5):633-8.

PMID:
17461697
14.
15.

Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.

Zulyniak MA, Perreault M, Gerling C, Spriet LL, Mutch DM.

Metabolism. 2013 Aug;62(8):1107-13. doi: 10.1016/j.metabol.2013.02.004. Epub 2013 Mar 21.

PMID:
23522836
16.

Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.

Siener R, Alteheld B, Terjung B, Junghans B, Bitterlich N, Stehle P, Metzner C.

Eur J Clin Nutr. 2010 Apr;64(4):410-8. doi: 10.1038/ejcn.2009.151. Epub 2010 Feb 17.

PMID:
20160750
17.
18.

Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.

Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK.

Am J Clin Nutr. 2010 May;91(5):1185-94. doi: 10.3945/ajcn.2009.29036. Epub 2010 Mar 24.

19.

Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.

Harris WS, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM.

Circulation. 2004 Sep 21;110(12):1645-9. Epub 2004 Sep 7. Erratum in: Circulation. 2004 Nov 9;110(19):3156.

Supplemental Content

Support Center